Healthcare Stocks To Research – November 6th

Moderna, Eli Lilly and Company, Natera, UnitedHealth Group, and Pfizer are the five Healthcare stocks to watch today, according to MarketBeat’s stock screener tool. Healthcare stocks are shares of publicly traded companies that provide healthcare-related products or services, such as pharmaceuticals, medical devices, biotechnology, hospitals, and health insurance. Investors may buy them to gain exposure to the healthcare industry, whose performance can be influenced by factors such as medical innovation, regulation, and demand for care. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.

Moderna (MRNA)

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines.

Moderna stock traded up $16.55 during mid-day trading on Friday, hitting $258.01. The company’s stock had a trading volume of 11,349,243 shares, compared to its average volume of 12,625,969. The firm has a market capitalization of $103.01 billion, a PE ratio of -32.14 and a beta of 1.16. Moderna has a 1 year low of $22.28 and a 1 year high of $267.50. The company has a current ratio of 2.29, a quick ratio of 2.18 and a debt-to-equity ratio of 0.09. The stock’s fifty day moving average is $189.62 and its two-hundred day moving average is $90.46.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

LLY stock traded up $4.12 during mid-day trading on Friday, hitting $1,368.85. 1,431,981 shares of the company were exchanged, compared to its average volume of 2,952,261. The firm has a market capitalization of $1.29 trillion, a P/E ratio of 44.43, a PEG ratio of 1.77 and a beta of 0.40. The company has a quick ratio of 1.00, a current ratio of 1.39 and a debt-to-equity ratio of 1.17. Eli Lilly and Company has a 12-month low of $850.51 and a 12-month high of $1,453.00. The business has a fifty day simple moving average of $1,211.30 and a 200-day simple moving average of $1,099.50.

Natera (NTRA)

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born.

Shares of NTRA stock traded down $50.49 on Friday, hitting $313.27. The stock had a trading volume of 3,066,377 shares, compared to its average volume of 1,444,544. The firm has a market capitalization of $45.16 billion, a P/E ratio of -230.15 and a beta of 1.55. The company’s 50 day moving average price is $380.81 and its 200-day moving average price is $269.30. Natera has a 1 year low of $181.00 and a 1 year high of $437.41.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

UNH traded down $1.54 on Friday, hitting $394.18. 2,410,790 shares of the company were exchanged, compared to its average volume of 7,225,673. The firm has a 50-day moving average price of $390.63 and a two-hundred day moving average price of $363.75. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group has a twelve month low of $255.96 and a twelve month high of $461.62. The company has a market cap of $353.20 billion, a price-to-earnings ratio of 22.48, a price-to-earnings-growth ratio of 1.48 and a beta of 0.51.

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

NYSE:PFE traded down $0.70 during mid-day trading on Friday, hitting $29.18. The stock had a trading volume of 23,668,330 shares, compared to its average volume of 39,815,031. The stock has a 50-day simple moving average of $28.72 and a two-hundred day simple moving average of $26.88. The company has a market capitalization of $166.29 billion, a PE ratio of 41.75, a PEG ratio of 2.04 and a beta of 0.31. Pfizer has a twelve month low of $23.62 and a twelve month high of $31.44. The company has a current ratio of 1.42, a quick ratio of 0.96 and a debt-to-equity ratio of 0.67.